Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HepNet Study-House is a specialized clinical research organization (CRO) and the operational arm of the German Liver Foundation (Deutsche Leberstiftung). Based in Hannover, Germany, the organization focuses exclusively on the management and execution of clinical trials in the field of hepatology. It provides comprehensive services for both investigator-initiated trials (IITs) and industry-sponsored studies, ranging from protocol development and regulatory submission to monitoring and data management. By leveraging its close ties to a vast network of liver specialists and academic centers, HepNet Study-House facilitates high-quality clinical research aimed at improving the treatment of viral hepatitis, liver cancer, and rare liver diseases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HepNet Study-House.